Efficacy and Safety of Mesotherapy With Minoxidil 0.5%/2ml for Androgenetic Alopecia in Female Patients

• Status: Unknown status
• Trial end date: 2013-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study aims to investigate the effectiveness and safety of mesotherapy for the treatment of female pattern alopecia.

• Sixty female subjects between 18 and 65 years diagnosed with female pattern hair loss will undergo mesotherapy sessions weekly for ten weeks.

• One group will receive 0.5%/2ml minoxidil application and a control group will receive application of placebo (saline 0.9%).

• Biopsy of the scalp, trichogram and trichoscopy (Fotofinder) will be performed before and 08 weeks after treatment as a method objective evaluation of the response

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Brasilia University Hospital
• Treatments: Minoxidil

Criteria

Inclusion Criteria:

• Women from 18 to 65 years old

• Androgenetic Alopecia (female pattern hair loss)

Exclusion Criteria:

• patients with alopecia areata or cicatricial alopecia

• pregnancy and breastfeeding

• have undergone any specific treatment in the last 06 months

• use of drugs with anti-androgenic properties

• patients with signs or symptoms of hyper-androgynism